Loading...
Welltower Inc. is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. The stock has strong growth potential in the healthcare real estate sector, supported by positive financial performance, bullish technical indicators, and favorable analyst ratings. While the RSI indicates the stock is overbought, the long-term growth outlook and stable dividend yield make it an attractive option.
The stock is in a bullish trend with MACD positively expanding (2.691), RSI_6 at 91.749 indicating overbought conditions, and moving averages showing strength (SMA_5 > SMA_20 > SMA_200). Key resistance levels are R1: 208.96 and R2: 216.311, with support at S1: 185.161.

Strong Q4 2025 results with 36% revenue growth and 32% EBITDA growth.
Analysts raised price targets (e.g., UBS to $240, Cantor Fitzgerald to $230).
Hedge funds are significantly increasing their positions (+104.41% last quarter).
Stable dividend yield of 4% and a quarterly dividend of $0.74 per share.
RSI indicates overbought conditions, suggesting potential short-term pullback.
Net income dropped by 37.63% YoY in Q3 2025, and EPS declined by 43.84%.
Welltower reported strong Q4 2025 results with revenue of $3.18 billion, exceeding expectations and growing 36% YoY. EBITDA grew 32%, reflecting operational efficiency. However, Q3 2025 showed a decline in net income (-37.63%) and EPS (-43.84%), though gross margin improved by 4.40% YoY.
Analysts maintain a positive outlook, with multiple upgrades and raised price targets (e.g., UBS to $240, Cantor Fitzgerald to $230). Analysts highlight strong growth in senior housing operating portfolios and a favorable macro environment for REITs in 2026.